STOCK TITAN

[Form 4] Zoetis Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zoetis Inc. director Antoinette Renee Leatherberry reported an equity award in the form of restricted stock units (RSUs). She acquired 1,936 RSUs at a stated price of $0.00 per unit, bringing this award to 1,936 RSUs. Each RSU represents a contingent right to receive one share of Zoetis common stock. According to the footnotes, these RSUs will vest and be settled in shares on the first anniversary of the grant date, February 18, 2026, subject to her continued service and certain earlier-vesting events. A separate line shows 1,619.3325 RSUs outstanding from a prior grant that is scheduled to vest and settle on February 19, 2025, under similar continued-service conditions.

Positive

  • None.

Negative

  • None.
Insider Leatherberry Antoinette Renee
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 1,936 $0.00 --
holding Restricted Stock Unit -- -- --
Holdings After Transaction: Restricted Stock Unit — 1,936 shares (Direct)
Footnotes (1)
  1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leatherberry Antoinette Renee

(Last) (First) (Middle)
C/O ZOETIS INC.
10 SYLVAN WAY

(Street)
PARSIPPANY NJ 07054

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit(1) (2) 02/18/2026 A 1,936 (3) (4) Common Stock 1,936 $0 1,936 D
Restricted Stock Unit(1) (2) (5) (4) Common Stock 1,619.3325 1,619.3325 D
Explanation of Responses:
1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.
3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
4. Not applicable.
5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
Remarks:
/s/ Brenda Santuccio, as Attorney-in-Fact 02/19/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zoetis (ZTS) director Antoinette Renee Leatherberry report?

Leatherberry reported receiving a grant of restricted stock units from Zoetis. The filing shows an award of 1,936 RSUs, each representing a contingent right to one share of Zoetis common stock, with vesting based on continued board service and specified events.

How many restricted stock units did the Zoetis (ZTS) director receive in this Form 4?

The director received 1,936 restricted stock units in this reported award. These RSUs are granted at a stated price of $0.00 per unit and will convert into Zoetis common shares upon vesting, assuming the director continues to serve and no earlier-vesting events occur.

When do the newly granted Zoetis (ZTS) RSUs for the director vest and settle?

The newly reported RSUs are scheduled to vest and settle on February 18, 2026. Vesting occurs on the first anniversary of the grant date, subject to the director’s continued service and potential earlier vesting and settlement upon certain specific events described in the award terms.

What does each Zoetis (ZTS) restricted stock unit granted to the director represent?

Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. This means that, upon vesting and settlement, the director will receive one Zoetis share for each RSU, provided service-based and other specified conditions in the award are satisfied.

Are there earlier Zoetis (ZTS) RSU awards to the director still outstanding?

Yes. The filing lists 1,619.3325 restricted stock units from a prior grant as outstanding. According to the footnotes, this earlier RSU award is scheduled to vest and be settled in Zoetis common stock on February 19, 2025, assuming continued service and subject to specified events.

Did the Zoetis (ZTS) director sell any shares in this Form 4 filing?

No sales are reported in this Form 4. The disclosed activity reflects an acquisition of 1,936 restricted stock units as a grant or award, plus an update to outstanding RSU holdings, with no open-market or other share dispositions indicated in the transaction data.